Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Cardiovascular problems already apparent in children with hemophilia A

Publish date:: April 9, 2020

Key clinical point: Negative cardiovascular health indicators were higher in children with hemophilia A.

Major finding: Myocardial performance index values in the hemophilia group were higher than in the control group (0.41 vs. 0.34; P = .004).

Study details: Biochemical, imaging, and metabolic comparison between 17 boys with severe hemophilia A and 23 healthy boys.

Disclosures: The study received no external funding. The authors did not report disclosures.

Citation:

Özdemir ZC et al. Thrombosis Res. 2020;189:102-7.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

PDAC: Tumor reduction after neoadjuvant therapy may predict postsurgical survival,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

‘Impressive’ local control with MRI-guided brachytherapy in cervical cancer,

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,

Must Reads in Bleeding Disorders

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

Hemochromatosis variants may confer 10-fold higher risk of liver cancer,

Hemophilia, von Willebrand disease do not increase postop complications for ACL reconstruction,

Mouth splints decrease risk of post–dental extraction bleeding in hemophilia,

Low VWF levels or blood group O not linked to intracerebral hemorrhage risk,